Anzeige
Mehr »
Mittwoch, 18.02.2026 - Börsentäglich über 12.000 News
Bio-Milliardenmarkt: Steht Organto vor der Neubewertung?!
Anzeige

Indizes

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Aktien

Kurs

%
News
24 h / 7 T
Aufrufe
7 Tage

Xetra-Orderbuch

Fonds

Kurs

%

Devisen

Kurs

%

Rohstoffe

Kurs

%

Themen

Kurs

%

Erweiterte Suche

Aktuelle News von Seeking Alpha

  • 24 h
  • letzte 200 News
ZeitAktuelle Nachrichten
DiExxon pledges to move fast in developing gas in Guyana
DiClearway Energy raises quarterly dividend by 1.6% to $0.4602/share
DiPalo Alto Networks in charts: Product revenue rises 22% Y/Y
DiLa-Z-Boy delivers FQ3 sales beat, but profits and guidance disappoints
DiGibson Energy reports Q4 results
DiInnospec Non-GAAP EPS of $1.50 beats by $0.26, revenue of $455.6M misses by $5.27M
DiHamilton Beach Brands declares $0.12 dividend
DiBerkshire Hathaway adds NY Times, boosts Chevron, pares BofA, Apple stakes among Q4 trades
DiEarnings Snapshot: Expand Energy beats Q4 results
DiSGH and Steel Dynamics submit A$15B final offer for BlueScope Steel
DiPrecision Optics GAAP EPS of -$0.23, revenue of $7.4M
DiSimmons First National authorizes $175M stock repurchase program
DiTechprecision GAAP EPS of -$0.15, revenue of $7.1M
DiCommunity Healthcare FFO of $0.49 in-line, revenue of $30.95M misses by $0.38M
DiPetVivo Holdings GAAP EPS of -$0.07, revenue of $0.28M
DiAltus Group to sell Canadian appraisals business to Newmark
DiMKS Instruments Non-GAAP EPS of $2.47 beats by $0.01, revenue of $1.03B beats by $10M
DiToll Brothers GAAP EPS of $2.19 beats by $0.07, revenue of $2.15B beats by $290M
DiJELD-WEN Holding Non-GAAP EPS of -$0.42 misses by $0.13, revenue of $802M beats by $56.78M
DiEQT Non-GAAP EPS of $0.90 beats by $0.14, revenue of $2.39B beats by $230M
DiWestwood to liquidate LBRTY Global Equity ETF
DiNANO Nuclear Energy reports Q1 results
DiElement Solutions Non-GAAP EPS of $0.37 beats by $0.01, revenue of $676.2M beats by $43.8M
DiHecla Mining GAAP EPS of $0.20 beats by $0.06, revenue of $448.11M beats by $92.83M
DiElite Pharmaceuticals GAAP EPS of $0.01, revenue of $31.6M